Evaluation of the consequences associated with diffuse vascular disease history in patients diagnosed with peripheral arterial disease: estimates from Saskatchewan health data
-
* Corresponding author: Michael Stokes michael.stokes@unitedbiosource.com
1 United BioSource Corporation, Lexington, MA, USA
2 United BioSource Corporation, Montréal, QC, Canada
3 sanofi-aventis Canada Inc., Laval, QC, Canada
4 Bristol-Myers Squibb Canada, St-Laurent, QC, Canada
BMC Cardiovascular Disorders 2010, 10:40 doi:10.1186/1471-2261-10-40
Published: 2 September 2010Additional files
Additional file 1:
Table S1. Patient characteristics at index diagnosis by diffuse vascular disease history. Table.
Format: DOCX Size: 15KB Download file
Additional file 2:
Table S2. Intervals between hospitalizations by type of diffuse vascular disease history. Table.
Format: DOCX Size: 15KB Download file
